0001728955-23-000001.txt : 20230810 0001728955-23-000001.hdr.sgml : 20230810 20230810135947 ACCESSION NUMBER: 0001728955-23-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20230810 DATE AS OF CHANGE: 20230810 EFFECTIVENESS DATE: 20230810 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Dracen Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001728955 IRS NUMBER: 812597193 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-489348 FILM NUMBER: 231158476 BUSINESS ADDRESS: STREET 1: 780 THIRD AVE. STREET 2: 18TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10017 BUSINESS PHONE: 410-659-2777 MAIL ADDRESS: STREET 1: 780 THIRD AVE. STREET 2: 18TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10017 D 1 primary_doc.xml X0708 D LIVE 0001728955 Dracen Pharmaceuticals, Inc. 9276 Scranton Road #200 San Diego CA CALIFORNIA 92121 410-659-2777 DELAWARE None None Corporation true Dennis M. Bilski 9276 Scranton Road #200 San Diego CA CALIFORNIA 92121 Executive Officer Asher Rubin 9276 Scranton Road #200 San Diego CA CALIFORNIA 92121 Executive Officer Drew Pardoll, M.D., Ph.D. 9276 Scranton Road #200 San Diego CA CALIFORNIA 92121 Director Jonathan Leff 9276 Scranton Road #200 San Diego CA CALIFORNIA 92121 Director Biotechnology Decline to Disclose 06b false 2023-06-11 false true false 2741 2785000 2285000 500000 false 6 0 0 45000 true false Dracen Pharmaceuticals, Inc. Dennis Bilski Dennis Bilski Acting Chief Financial Officer 2023-08-10